{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T14:41:07Z","timestamp":1788014467475,"version":"build-2784847793"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,1,10]],"date-time":"2014-01-10T00:00:00Z","timestamp":1389312000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2014,1,10]],"date-time":"2014-01-10T00:00:00Z","timestamp":1389312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Interval cancers are tumors arising after a negative screening episode and before the next screening invitation. They can be classified into true interval cancers, false-negatives, minimal-sign cancers, and occult tumors based on mammographic findings in screening and diagnostic mammograms. This study aimed to describe tumor-related characteristics and the association of breast density and tumor phenotype within four interval cancer categories.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We included 2,245 invasive tumors (1,297 screening-detected and 948 interval cancers) diagnosed from 2000 to 2009 among 645,764 women aged 45 to 69 who underwent biennial screening in Spain. Interval cancers were classified by a semi-informed retrospective review into true interval cancers (n\u2009=\u2009455), false-negatives (n\u2009=\u2009224), minimal-sign (n\u2009=\u2009166), and occult tumors (n\u2009=\u2009103). Breast density was evaluated using Boyd\u2019s scale and was conflated into: &lt;25%; 25 to 50%; 50 to 75%; &gt;75%. Tumor-related information was obtained from cancer registries and clinical records. Tumor phenotype was defined as follows: luminal A: ER+\/HER2- or PR+\/HER2-; luminal B: ER+\/HER2+ or PR+\/HER2+; HER2: ER-\/PR-\/HER2+; triple-negative: ER-\/PR-\/HER2-. The association of tumor phenotype and breast density was assessed using a multinomial logistic regression model. Adjusted odds ratios (OR) and 95% confidence intervals (95% CI) were calculated. All statistical tests were two-sided.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Forty-eight percent of interval cancers were true interval cancers and 23.6% false-negatives. True interval cancers were associated with HER2 and triple-negative phenotypes (OR\u2009=\u20091.91 (95% CI:1.22-2.96), OR\u2009=\u20092.07 (95% CI:1.42-3.01), respectively) and extremely dense breasts (&gt;75%) (OR\u2009=\u20091.67 (95% CI:1.08-2.56)). However, among true interval cancers a higher proportion of triple-negative tumors was observed in predominantly fatty breasts (&lt;25%) than in denser breasts (28.7%, 21.4%, 11.3% and 14.3%, respectively; &lt;0.001). False-negatives and occult tumors had similar phenotypic characteristics to screening-detected cancers, extreme breast density being strongly associated with occult tumors (OR\u2009=\u20096.23 (95% CI:2.65-14.66)). Minimal-sign cancers were biologically close to true interval cancers but showed no association with breast density.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings revealed that both the distribution of tumor phenotype and breast density play specific and independent roles in each category of interval cancer. Further research is needed to understand the biological basis of the overrepresentation of triple-negative phenotype among predominantly fatty breasts in true interval cancers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/bcr3595","type":"journal-article","created":{"date-parts":[[2014,1,10]],"date-time":"2014-01-10T12:00:55Z","timestamp":1389355255000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Tumor phenotype and breast density in distinct categories of interval cancer: results of population-based mammography screening in Spain"],"prefix":"10.1186","volume":"16","author":[{"given":"Laia","family":"Domingo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"Salas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Zubizarreta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Bar\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garbi\u00f1e","family":"Sarriugarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Barata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefa","family":"Ib\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Blanch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Puig-Vives","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Bel\u00e9n","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Castells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Sala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,10]]},"reference":[{"key":"3554_CR1","volume-title":"European guidelines for quality assurance in breast cancer screening and diagnosis","author":"N Perry","year":"2006","unstructured":"Perry N, Broeders M, de Wolf C, T\u00f6rnberg C, Holland R, von Karsa L: European guidelines for quality assurance in breast cancer screening and diagnosis. 2006, Luxembourg: Office for Official Publications of the European Communities, 4","edition":"4"},{"key":"3554_CR2","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S1470-2045(06)70617-9","volume":"7","author":"N Houssami","year":"2006","unstructured":"Houssami N, Irwig L, Ciatto S: Radiological surveillance of interval breast cancers in screening programmes. Lancet Oncol. 2006, 7: 259-265. 10.1016\/S1470-2045(06)70617-9.","journal-title":"Lancet Oncol"},{"key":"3554_CR3","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1080\/02841850802403730","volume":"49","author":"S Hofvind","year":"2008","unstructured":"Hofvind S, Geller B, Skaane P: Mammographic features and histopathological findings of interval breast cancers. Acta Radiol. 2008, 49: 975-981. 10.1080\/02841850802403730.","journal-title":"Acta Radiol"},{"key":"3554_CR4","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s10552-010-9541-6","volume":"21","author":"L Domingo","year":"2010","unstructured":"Domingo L, Sala M, Servitja S, Corominas JM, Ferrer F, Martinez J, Macia F, Quintana MJ, Albanell J, Castells X: Phenotypic characterization and risk factors for interval breast cancers in a population-based breast cancer screening program in Barcelona, Spain. Cancer Causes Control. 2010, 21: 1155-1164. 10.1007\/s10552-010-9541-6.","journal-title":"Cancer Causes Control"},{"key":"3554_CR5","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s003300050452","volume":"8","author":"B Vitak","year":"1998","unstructured":"Vitak B: Invasive interval cancers in the Ostergotland Mammographic Screening Programme: radiological analysis. Eur Radiol. 1998, 8: 639-646. 10.1007\/s003300050452.","journal-title":"Eur Radiol"},{"key":"3554_CR6","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1097\/CEJ.0b013e3282f75ef5","volume":"17","author":"M Bare","year":"2008","unstructured":"Bare M, Sentis M, Galceran J, Ameijide A, Andreu X, Ganau S, Tortajada L, Planas J: Interval breast cancers in a community screening programme: frequency, radiological classification and prognostic factors. Eur J Cancer Prev. 2008, 17: 414-421. 10.1097\/CEJ.0b013e3282f75ef5.","journal-title":"Eur J Cancer Prev"},{"key":"3554_CR7","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1158\/1055-9965.EPI-04-0394","volume":"14","author":"K Collett","year":"2005","unstructured":"Collett K, Stefansson IM, Eide J, Braaten A, Wang H, Eide GE, Thoresen SO, Foulkes WD, Akslen LA: A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors. Cancer Epidemiol Biomarkers Prev. 2005, 14: 1108-1112. 10.1158\/1055-9965.EPI-04-0394.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"3554_CR8","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/jnci\/djr138","volume":"103","author":"VA Kirsh","year":"2011","unstructured":"Kirsh VA, Chiarelli AM, Edwards SA, O\u2019Malley FP, Shumak RS, Yaffe MJ, Boyd NF: Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program. J Natl Cancer Inst. 2011, 103: 942-950. 10.1093\/jnci\/djr138.","journal-title":"J Natl Cancer Inst"},{"key":"3554_CR9","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1200\/JCO.2011.37.6434","volume":"30","author":"A Musolino","year":"2012","unstructured":"Musolino A, Michiara M, Conti GM, Boggiani D, Zatelli M, Palleschi D, Bella MA, Sgargi P, Di Blasio B, Ardizzoni A: Human epidermal growth factor receptor 2 status and interval breast cancer in a population-based cancer registry study. J Clin Oncol. 2012, 30: 2362-2368. 10.1200\/JCO.2011.37.6434.","journal-title":"J Clin Oncol"},{"key":"3554_CR10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00432-012-1304-1","volume":"139","author":"A Caldarella","year":"2013","unstructured":"Caldarella A, Puliti D, Crocetti E, Bianchi S, Vezzosi V, Apicella P, Biancalani M, Giannini A, Urso C, Zolfanelli F, Paci E: Biological characteristics of interval cancers: a role for biomarkers in the breast cancer screening. J Cancer Res Clin Oncol. 2013, 139: 181-185. 10.1007\/s00432-012-1304-1.","journal-title":"J Cancer Res Clin Oncol"},{"key":"3554_CR11","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/bcr2574","volume":"12","author":"RD Chacon","year":"2010","unstructured":"Chacon RD, Costanzo MV: Triple-negative breast cancer. Breast Cancer Res. 2010, 12: S3-","journal-title":"Breast Cancer Res"},{"key":"3554_CR12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/jama.1996.03540010035027","volume":"276","author":"K Kerlikowske","year":"1996","unstructured":"Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V: Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA. 1996, 276: 33-38. 10.1001\/jama.1996.03540010035027.","journal-title":"JAMA"},{"key":"3554_CR13","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1093\/jnci\/92.13.1081","volume":"92","author":"MT Mandelson","year":"2000","unstructured":"Mandelson MT, Oestreicher N, Porter PL, White D, Finder CA, Taplin SH, White E: Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst. 2000, 92: 1081-1087. 10.1093\/jnci\/92.13.1081.","journal-title":"J Natl Cancer Inst"},{"key":"3554_CR14","doi-asserted-by":"publisher","first-page":"R9","DOI":"10.1186\/bcr3380","volume":"15","author":"M Pollan","year":"2013","unstructured":"Pollan M, Ascunce N, Ederra M, Murillo A, Erdozain N, Ales-Martinez JE, Pastor-Barriuso R: Mammographic density and risk of breast cancer according to tumor characteristics and mode of detection: a Spanish population-based case\u2013control study. Breast Cancer Res. 2013, 15: R9-10.1186\/bcr3380.","journal-title":"Breast Cancer Res"},{"key":"3554_CR15","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1056\/NEJMoa062790","volume":"356","author":"NF Boyd","year":"2007","unstructured":"Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, Jong RA, Hislop G, Chiarelli A, Minkin S, Yaffe MJ: Mammographic density and the risk and detection of breast cancer. N Engl J Med. 2007, 356: 227-236. 10.1056\/NEJMoa062790.","journal-title":"N Engl J Med"},{"key":"3554_CR16","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/bcr1831","volume":"10","author":"LJ Martin","year":"2008","unstructured":"Martin LJ, Boyd NF: Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence. Breast Cancer Res. 2008, 10: 201-10.1186\/bcr1831.","journal-title":"Breast Cancer Res"},{"key":"3554_CR17","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s10549-012-2127-0","volume":"134","author":"L Eriksson","year":"2012","unstructured":"Eriksson L, Czene K, Rosenberg L, Humphreys K, Hall P: The influence of mammographic density on breast tumor characteristics. Breast Cancer Res Treat. 2012, 134: 859-866. 10.1007\/s10549-012-2127-0.","journal-title":"Breast Cancer Res Treat"},{"key":"3554_CR18","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1093\/jnci\/djr225","volume":"103","author":"L Yaghjyan","year":"2011","unstructured":"Yaghjyan L, Colditz GA, Collins LC, Schnitt SJ, Rosner B, Vachon C, Tamimi RM: Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. J Natl Cancer Inst. 2011, 103: 1179-1189. 10.1093\/jnci\/djr225.","journal-title":"J Natl Cancer Inst"},{"key":"3554_CR19","doi-asserted-by":"publisher","first-page":"iii43","DOI":"10.1093\/annonc\/mdq085","volume":"21","author":"N Ascunce","year":"2010","unstructured":"Ascunce N, Salas D, Zubizarreta R, Almazan R, Ibanez J, Ederra M: Cancer screening in Spain. Ann Oncol. 2010, 21: iii43-iii51.","journal-title":"Ann Oncol"},{"key":"3554_CR20","volume-title":"Breast Imaging Reporting and Data System Atlas (BI-RADS\u00aeAtlas)","author":"American College of Radiology (ACR)","year":"2003","unstructured":"American College of Radiology (ACR): Breast Imaging Reporting and Data System Atlas (BI-RADS\u00aeAtlas). 2003, Reston, VA: American College of Radiology (ACR)"},{"key":"3554_CR21","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/jnci\/87.9.670","volume":"87","author":"NF Boyd","year":"1995","unstructured":"Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, Lockwood GA, Tritchler DL, Yaffe MJ: Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst. 1995, 87: 670-675. 10.1093\/jnci\/87.9.670.","journal-title":"J Natl Cancer Inst"},{"key":"3554_CR22","first-page":"1133","volume":"7","author":"NF Boyd","year":"1998","unstructured":"Boyd NF, Lockwood GA, Byng JW, Tritchler DL, Yaffe MJ: Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 1998, 7: 1133-1144.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"3554_CR23","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.5858\/134.7.e48","volume":"134","author":"ME Hammond","year":"2010","unstructured":"Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M, Hicks DG, Lester S, Love R, Mangu PB, McShane L, Miller K, Osborne CK, Paik S, Perlmutter J, Rhodes A, Sasano H, Schwartz JN, Sweep FC, Taube S, Torlakovic EE, Valenstein P, Viale G, Visscher D, Wheeler T, Williams RB, et al: American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Arch Pathol Lab Med. 2010, 134: e48-e72.","journal-title":"Arch Pathol Lab Med"},{"key":"3554_CR24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5858\/2007-131-18-ASOCCO","volume":"131","author":"TM Wheeler","year":"2007","unstructured":"Wheeler TM, Hayes DF, Van DV, Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH: American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med. 2007, 131: 18-43.","journal-title":"Arch Pathol Lab Med"},{"key":"3554_CR25","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","volume":"19","author":"CW Elston","year":"1991","unstructured":"Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991, 19: 403-410. 10.1111\/j.1365-2559.1991.tb00229.x.","journal-title":"Histopathology"},{"key":"3554_CR26","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","volume":"22","author":"A Goldhirsch","year":"2011","unstructured":"Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thurlimann B, Senn HJ: Strategies for subtypes\u2013dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol. 2011, 22: 1736-1747. 10.1093\/annonc\/mdr304.","journal-title":"Ann Oncol"},{"key":"3554_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/0470114754","volume-title":"An Introduction to Categorical Data Analysis","author":"A Agresti","year":"2007","unstructured":"Agresti A: An Introduction to Categorical Data Analysis. 2007, New York: Willey, 2","edition":"2"},{"key":"3554_CR28","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.breast.2007.05.010","volume":"16","author":"S Ciatto","year":"2007","unstructured":"Ciatto S, Catarzi S, Lamberini MP, Risso G, Saguatti G, Abbattista T, Martinelli F, Houssami N: Interval breast cancers in screening: the effect of mammography review method on classification. Breast. 2007, 16: 646-652. 10.1016\/j.breast.2007.05.010.","journal-title":"Breast"},{"key":"3554_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3816\/CBC.2011.n.005","volume":"11","author":"D Rayson","year":"2011","unstructured":"Rayson D, Payne JI, Abdolell M, Barnes PJ, MacIntosh RF, Foley T, Younis T, Burns A, Caines J: Comparison of clinical-pathologic characteristics and outcomes of true interval and screen-detected invasive breast cancer among participants of a Canadian breast screening program: a nested case\u2013control study. Clin Breast Cancer. 2011, 11: 27-32. 10.3816\/CBC.2011.n.005.","journal-title":"Clin Breast Cancer"},{"key":"3554_CR30","first-page":"2682","volume":"5","author":"M Crosier","year":"1999","unstructured":"Crosier M, Scott D, Wilson RG, Griffiths CD, May FE, Westley BR: Differences in Ki67 and c-erbB2 expression between screen-detected and true interval breast cancers. Clin Cancer Res. 1999, 5: 2682-2688.","journal-title":"Clin Cancer Res"},{"key":"3554_CR31","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1148\/radiol.12102348","volume":"266","author":"JI Payne","year":"2013","unstructured":"Payne JI, Caines JS, Gallant J, Foley TJ: A review of interval breast cancers diagnosed among participants of the Nova Scotia Breast Screening Program. Radiology. 2013, 266: 96-103. 10.1148\/radiol.12102348.","journal-title":"Radiology"},{"key":"3554_CR32","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1007\/s003300050693","volume":"9","author":"B Vitak","year":"1999","unstructured":"Vitak B, Olsen KE, Manson JC, Arnesson LG, Stal O: Tumour characteristics and survival in patients with invasive interval breast cancer classified according to mammographic findings at the latest screening: a comparison of true interval and missed interval cancers. Eur Radiol. 1999, 9: 460-469. 10.1007\/s003300050693.","journal-title":"Eur Radiol"},{"key":"3554_CR33","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.canep.2010.11.011","volume":"35","author":"SM Conroy","year":"2011","unstructured":"Conroy SM, Pagano I, Kolonel LN, Maskarinec G: Mammographic density and hormone receptor expression in breast cancer: the Multiethnic Cohort Study. Cancer Epidemiol. 2011, 35: 448-452. 10.1016\/j.canep.2010.11.011.","journal-title":"Cancer Epidemiol"},{"key":"3554_CR34","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1524-4741.2010.00907.x","volume":"16","author":"J Ding","year":"2010","unstructured":"Ding J, Warren R, Girling A, Thompson D, Easton D: Mammographic density, estrogen receptor status and other breast cancer tumor characteristics. Breast J. 2010, 16: 279-289. 10.1111\/j.1524-4741.2010.00907.x.","journal-title":"Breast J"},{"key":"3554_CR35","first-page":"243","volume":"10","author":"YP Guo","year":"2001","unstructured":"Guo YP, Martin LJ, Hanna W, Banerjee D, Miller N, Fishell E, Khokha R, Boyd NF: Growth factors and stromal matrix proteins associated with mammographic densities. Cancer Epidemiol Biomarkers Prev. 2001, 10: 243-248.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"3554_CR36","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/jnci\/djq526","volume":"103","author":"XR Yang","year":"2011","unstructured":"Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, Gaudet M, Schmidt MK, Broeks A, Cox A, Fasching PA, Hein R, Spurdle AB, Blows F, Driver K, Flesch-Janys D, Heinz J, Sinn P, Vrieling A, Heikkinen T, Aittomaki K, Heikkila P, Blomqvist C, Lissowska J, Peplonska B, Chanock S, Figueroa J, Brinton L, Hall P, Czene K, et al: Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst. 2011, 103: 250-263. 10.1093\/jnci\/djq526.","journal-title":"J Natl Cancer Inst"},{"key":"3554_CR37","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/sj.bjc.6601548","volume":"90","author":"S Ciatto","year":"2004","unstructured":"Ciatto S, Visioli C, Paci E, Zappa M: Breast density as a determinant of interval cancer at mammographic screening. Br J Cancer. 2004, 90: 393-396. 10.1038\/sj.bjc.6601548.","journal-title":"Br J Cancer"},{"key":"3554_CR38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/0003-4819-155-1-201107050-00003","volume":"155","author":"JT Schousboe","year":"2011","unstructured":"Schousboe JT, Kerlikowske K, Loh A, Cummings SR: Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann Intern Med. 2011, 155: 10-20. 10.7326\/0003-4819-155-1-201107050-00003.","journal-title":"Ann Intern Med"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr3595.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/bcr3595\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr3595.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T06:42:35Z","timestamp":1728369755000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/bcr3595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,10]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,2]]}},"alternative-id":["3554"],"URL":"https:\/\/doi.org\/10.1186\/bcr3595","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,10]]},"assertion":[{"value":"23 May 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R3"}}